BioCentury
ARTICLE | Finance

Event planner

Investors' top names, milestones and meetings in 4Q15

October 5, 2015 7:00 AM UTC

For investors who are not inclined to sit it out until the volatility abates, the fourth quarter is bursting with late-stage catalysts. There are no fewer than 17 PDUFA dates on the calendar before year end, and at least 11 Phase III data events.

The most eagerly anticipated event of 4Q15 - an FDA panel of Duchenne muscular dystrophy therapies - also is unconfirmed, as the agency still hasn't set a meeting date...